HSBC Holdings’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-5,000
Closed -$186K – 3029
2026
Q1
$186K Buy
+5,000
New +$206K ﹤0.01% 2632
2025
Q4
– Sell
-6,500
Closed -$272K – 3014
2025
Q3
$272K Sell
6,500
-4,500
-41% -$198K ﹤0.01% 2367
2025
Q2
$484K Hold
11,000
– – ﹤0.01% 2175
2025
Q1
$554K Sell
11,000
-4,500
-29% -$223K ﹤0.01% 2023
2024
Q4
$666K Sell
15,500
-3,500
-18% -$148K ﹤0.01% 2013
2024
Q3
$745K Hold
19,000
– – ﹤0.01% 1820
2024
Q2
$608K Hold
19,000
– – ﹤0.01% 1883
2024
Q1
$626K Hold
19,000
– – ﹤0.01% 1994
2023
Q4
$659K Buy
+19,000
New +$655K ﹤0.01% 1938

Other funds holding G

HSBC Holdings's G Position: Q2 2026 in Review

HSBC Holdings increased its Genpact (G) stake by 16% in Q2 2026, buying an estimated $693K and bringing the position to 157,087 shares worth $4.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

HSBC Holdings first reported a position in G in Q1 2014 and has held it in 35 quarters since. The position peaked at $15.8M in Q4 2017. 479 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • HSBC Holdings held 157,087 shares of Genpact worth $4.28M as of Q2 2026.
  • HSBC Holdings bought 21,105 Genpact shares in Q2 2026, an estimated $693K.
  • Genpact made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1274 holding.
  • HSBC Holdings first reported a position in Genpact in Q1 2014 and has held it in 35 quarters since.
  • HSBC Holdings's Genpact position peaked at $15.8M in Q4 2017.
  • 479 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.